Saba Capital Management, L.P. Acquires 93,967 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZGet Free Report) major shareholder Saba Capital Management, L.P. bought 93,967 shares of the business’s stock in a transaction on Monday, February 5th. The stock was acquired at an average cost of 15.56 per share, for a total transaction of 1,462,126.52. Following the acquisition, the insider now directly owns 18,690,059 shares of the company’s stock, valued at 290,817,318.04. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

  • On Friday, February 2nd, Saba Capital Management, L.P. bought 53,462 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average cost of 15.60 per share, for a total transaction of 834,007.20.
  • On Wednesday, January 31st, Saba Capital Management, L.P. bought 134,564 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average cost of 15.50 per share, for a total transaction of 2,085,742.00.
  • On Monday, January 29th, Saba Capital Management, L.P. bought 264,206 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average cost of 15.41 per share, for a total transaction of 4,071,414.46.
  • On Friday, January 26th, Saba Capital Management, L.P. bought 347,814 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average cost of 15.26 per share, for a total transaction of 5,307,641.64.
  • On Wednesday, January 24th, Saba Capital Management, L.P. purchased 113,312 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average cost of 15.13 per share, for a total transaction of 1,714,410.56.
  • On Monday, January 22nd, Saba Capital Management, L.P. purchased 54,477 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average cost of 15.06 per share, for a total transaction of 820,423.62.
  • On Thursday, January 18th, Saba Capital Management, L.P. purchased 41,792 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average cost of 14.89 per share, for a total transaction of 622,282.88.
  • On Tuesday, January 16th, Saba Capital Management, L.P. purchased 19,207 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average cost of 15.10 per share, for a total transaction of 290,025.70.
  • On Thursday, January 11th, Saba Capital Management, L.P. purchased 72,085 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average cost of 15.17 per share, for a total transaction of 1,093,529.45.
  • On Wednesday, December 20th, Saba Capital Management, L.P. acquired 146,904 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average price of 14.67 per share, for a total transaction of 2,155,081.68.

BlackRock Health Sciences Term Trust Trading Up 0.6 %

NYSE BMEZ opened at 15.73 on Wednesday. BlackRock Health Sciences Term Trust has a 12 month low of 12.93 and a 12 month high of 16.95. The company’s 50 day simple moving average is 14.80 and its 200 day simple moving average is 14.69.

BlackRock Health Sciences Term Trust Cuts Dividend

The business also recently disclosed a monthly dividend, which will be paid on Thursday, February 29th. Investors of record on Thursday, February 15th will be paid a dividend of $0.09 per share. The ex-dividend date of this dividend is Wednesday, February 14th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 6.87%.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in BMEZ. Raymond James Financial Services Advisors Inc. grew its position in BlackRock Health Sciences Term Trust by 15.8% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 69,130 shares of the company’s stock worth $1,387,000 after buying an additional 9,413 shares during the last quarter. Cambridge Investment Research Advisors Inc. grew its position in BlackRock Health Sciences Term Trust by 37.5% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 23,480 shares of the company’s stock worth $471,000 after buying an additional 6,407 shares during the last quarter. First Trust Advisors LP grew its position in BlackRock Health Sciences Term Trust by 8.3% in the first quarter. First Trust Advisors LP now owns 86,674 shares of the company’s stock worth $1,739,000 after buying an additional 6,654 shares during the last quarter. Quantedge Capital Pte Ltd grew its position in BlackRock Health Sciences Term Trust by 448.0% in the first quarter. Quantedge Capital Pte Ltd now owns 69,600 shares of the company’s stock worth $1,396,000 after buying an additional 56,900 shares during the last quarter. Finally, City of London Investment Management Co. Ltd. grew its position in BlackRock Health Sciences Term Trust by 45.6% in the first quarter. City of London Investment Management Co. Ltd. now owns 218,424 shares of the company’s stock worth $4,376,000 after buying an additional 68,452 shares during the last quarter.

BlackRock Health Sciences Term Trust Company Profile

(Get Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

Read More

Insider Buying and Selling by Quarter for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.